ENTX
Entera Bio (ENTX)
$09
About Entera Bio (ENTX)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Details
Daily high
$2.12
Daily low
$2.03
Price at open
$2.06
52 Week High
$3.22
52 Week Low
$1.50
Market cap
95.4M
Dividend yield
0.00%
Volume
20,073
Avg. volume
80,100
P/E ratio
-8.50
Entera Bio News
Details
Daily high
$2.12
Daily low
$2.03
Price at open
$2.06
52 Week High
$3.22
52 Week Low
$1.50
Market cap
95.4M
Dividend yield
0.00%
Volume
20,073
Avg. volume
80,100
P/E ratio
-8.50